Ironwood Pharmaceuticals shares overvalued, says Cantor After the FDA approved Ironwood's Linzess for certain cases of irritable bowel syndrome and constipation, Cantor doesn't expect the drug to become profitable until 2019. The firm anticipates that other research firms will become more negative towards the stock, and Cantor maintains a Sell rating on the shares.
News For IRWD From The Last 14 Days
Check below for free stories on IRWD the last two weeks.
On The Fly: Analyst Downgrade Summary Today's noteworthy downgrades include: C&J Energy (CJES) downgraded to Neutral from Buy at Goldman.... Corcept Therapeutics (CORT) downgraded to Neutral from Overweight at Piper Jaffray... Exelon (EXC) downgraded to Neutral from Buy at ISI Group... HeartWare (HTWR) downgraded to Neutral from Outperform at Credit Suisse... Kimco Realty (KIM) downgraded to Neutral from Buy at Goldman... Moody's (MCO) downgraded to Outperform from Strong Buy at Raymond James... PACCAR (PCAR) downgraded to Neutral from Buy at BofA/Merrill... Unum Group (UNM) downgraded to Hold from Buy at Deutsche Bank... Weatherford (WFT) downgraded to Neutral from Strong Buy at ISI Group... Churchill Downs (CHDN) downgraded to Neutral from Long-Term Buy at Hilliard Lyons... Electronic Arts (EA) downgraded to Sell from Hold at Hudson Square... Summit State Bank (SSBI) downgraded to Neutral from Long-Term Buy at Hilliard Lyons... Ironwood (IRWD) downgraded to Neutral from Outperform at Cowen... Oil States (OIS) downgraded to Neutral from Add at Capital One... CYS Investments (CYS) downgraded to Neutral from Buy at Nomura... American Capital Agency (AGNC) downgraded to Neutral from Buy at Nomura... Integrys Energy (TEG) downgraded to Neutral from Buy at DA Davidson... Oil States (OIS) downgraded to Accumulate from Buy at Tudor Pickering... Delcath Systems (DCTH) downgraded to Market Perform from Outperform at JMP Securities... Comerica (CMA) downgraded to Neutral from Buy at BTIG... Eldorado Gold (EGO) downgraded to Sector Perform from Outperform at RBC Capital